Pharmaceutical companies working in partnership with technology providers

We expedite the commercial adoption of predictive drug safety technologies by giving innovators a unique platform to showcase their technologies.

Benefits of Technology Evaluation projects:

The program provides technology sponsors with a channel to reach multiple pharmaceutical companies simultaneously. By leveraging a shared library of proprietary compounds (with correlated in vivo data) created by the pharma companies, technology innovators are able to further quaify their platforms.

• More than 33% of participting pharma companies purchase/lease the technology or service following completion of the Technology Evaluation Consortium.
• Member companies, making up Technology Evalution team, provide direct input into the technology sponsor's produt design and/or business model.
• The term of Technology Evalution Consortia is typicaly 3-6 months

Current projects